Clinical Trials Directory

Trials / Completed

CompletedNCT02665013

Reducing Delay of Vaccination in Children Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
824 (actual)
Sponsor
Kaiser Permanente · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial will assess the effectiveness of a tailored message intervention on decreasing infant undervaccination.

Detailed description

This intervention is based on the concept of "message tailoring," whereby each mother is provided with individually customized vaccine- related information that addresses their unique concerns, values, questions and logistical barriers. Message tailoring is an evidence-based health messaging strategy that has been shown to improve compliance with a wide variety of preventive health care behaviors among diverse patient populations. In this three-armed trial the investigator will examine how providing mothers with multiple "doses" of a tailored versus untailored version of our intervention compares with "usual care" for the impact on infant under-vaccination. Secondary outcomes will include maternal vaccine-related attitudes (including level of vaccine hesitancy), alignment of maternal values with provider recommendations, and self-efficacy for overcoming logistical barriers to vaccination.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTailoredPregnant women will be recruited to the study. The intervention will be delivered to participants prior to the child's 2 month well child visit, when the child is between 4 and 6 months of age, and when the child is 10-12 months of age. The first intervention occurs at enrollment in the study. Participants in the tailored intervention arm will receive vaccine information tailored specific to her concerns and values at each intervention point.
BEHAVIORALUntailoredPregnant women will be recruited to the study. The intervention will be delivered to participants prior to the child's 2 month well child visit, when the child is between 4 and 6 months of age, and when the child is 10-12 months of age. The first intervention occurs at enrollment in the study. Participants in the untailored arm will receive vaccine information at each intervention time point, but it will not be tailored to her specific concerns.

Timeline

Start date
2016-04-01
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2016-01-27
Last updated
2019-06-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02665013. Inclusion in this directory is not an endorsement.